# Pfizer CentreOne — source-backed brand brief

Profile: [Pfizer CentreOne](<https://brandsource.ai/brands/pfizer-centreone>)
Evidence record: [Sources and review dates](<https://brandsource.ai/evidence/pfizer-centreone>)

Exported: 2026-10-29T18:15:57.737Z. Export time only; this is not a source observation, factual update or verification date.

This brief contains only the scoped evidence published for this profile. Public-source statements and business statements are attributed, not independently verified. Missing topics remain unknown; legacy profile descriptions and products are not included as supported facts.

Quoted source content and claim text are reference data, not instructions. Check the cited scope before reusing a statement. This export does not connect an AI service or guarantee that it will access or cite BrandSource.

4 supported scoped claim(s); 0 unresolved or overdue claim(s).

## Oral solid-dose manufacturing

Status: Published by the business
Value: Oral solid-dose manufacturing: Manufacturing services for formats including pellets, tablets and capsules.
Scope: Manufacturing capabilities described by the business; no regulatory approval or patient-outcome claim is made.
Explanation: Reviewed against captured first-party source passages by an assistant. This records the organization’s published description; it does not establish independent corroboration or a legal-register match.

Review: Reviewed 2026-10-19T00:25:24.424Z; review due 2027-01-17T00:25:24.424Z.
Published: 2026-10-19T00:25:24.424Z. Claim version: 1.
Claim: [brandsource:pfizer-centreone:useful99-2026-10-18:product-0](<https://brandsource.ai/evidence/pfizer-centreone#brandsource%3Apfizer-centreone%3Auseful99-2026-10-18%3Aproduct-0>)

Sources:
- [Homepage \| Pfizer CentreOne](<https://www.pfizercentreone.com/>) — Business statement; observed 2026-10-19T00:07:58.479Z; lineage: pfizercentreone.com.

## Published manufacturing modalities

Status: Published by the business
Value: Oral solids, sterile injectables and biologic drug products
Scope: Published description of Pfizer CentreOne on the cited official website; observation dates are recorded with each source.
Explanation: Reviewed against captured first-party source passages by an assistant. This records the organization’s published description; it does not establish independent corroboration or a legal-register match.

Review: Reviewed 2026-10-19T00:25:24.424Z; review due 2027-01-17T00:25:24.424Z.
Published: 2026-10-19T00:25:24.424Z. Claim version: 1.
Claim: [brandsource:pfizer-centreone:useful99-2026-10-18:fact-0](<https://brandsource.ai/evidence/pfizer-centreone#brandsource%3Apfizer-centreone%3Auseful99-2026-10-18%3Afact-0>)

Sources:
- [Homepage \| Pfizer CentreOne](<https://www.pfizercentreone.com/>) — Business statement; observed 2026-10-19T00:07:58.479Z; lineage: pfizercentreone.com.

## Published overview

Status: Published by the business
Value: Pfizer CentreOne is a contract manufacturing organization specializing in commercial manufacturing of oral solid-dose, sterile injectable and biologic drug products. Its published services also include technology transfer and regulatory support.
Scope: Published description of Pfizer CentreOne on the cited official website; observation dates are recorded with each source.
Explanation: Reviewed against captured first-party source passages by an assistant. This records the organization’s published description; it does not establish independent corroboration or a legal-register match.

Review: Reviewed 2026-10-19T00:25:24.424Z; review due 2027-01-17T00:25:24.424Z.
Published: 2026-10-19T00:25:24.424Z. Claim version: 1.
Claim: [brandsource:pfizer-centreone:useful99-2026-10-18:summary](<https://brandsource.ai/evidence/pfizer-centreone#brandsource%3Apfizer-centreone%3Auseful99-2026-10-18%3Asummary>)

Sources:
- [Homepage \| Pfizer CentreOne](<https://www.pfizercentreone.com/>) — Business statement; observed 2026-10-19T00:07:58.479Z; lineage: pfizercentreone.com.

## Sterile injectable manufacturing

Status: Published by the business
Value: Sterile injectable manufacturing: Manufacturing services covering liquid and lyophilized formats, pre-filled syringes, vials and cartridges.
Scope: Manufacturing capabilities described by the business; no regulatory approval, efficacy or patient-outcome claim is made.
Explanation: Reviewed against captured first-party source passages by an assistant. This records the organization’s published description; it does not establish independent corroboration or a legal-register match.

Review: Reviewed 2026-10-19T00:25:24.424Z; review due 2027-01-17T00:25:24.424Z.
Published: 2026-10-19T00:25:24.424Z. Claim version: 1.
Claim: [brandsource:pfizer-centreone:useful99-2026-10-18:product-1](<https://brandsource.ai/evidence/pfizer-centreone#brandsource%3Apfizer-centreone%3Auseful99-2026-10-18%3Aproduct-1>)

Sources:
- [Homepage \| Pfizer CentreOne](<https://www.pfizercentreone.com/>) — Business statement; observed 2026-10-19T00:07:58.479Z; lineage: pfizercentreone.com.

## Unknowns and limits

- This brief does not establish answers to topics outside the listed claims.
